
Voglimark 0.2mg Tablet
Marketer
Elixir Life Care Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglimark 0.2mg Tablet
Diabetol 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when dietary modifications and other anti-diabetic therapies prove insufficient, Diabetol 0.2mg should be administered immediately prior to meals. Dosage and frequency are determined individually by your physician to optimize glycemic control. Abrupt cessation is contraindicated; discontinuing without medical supervision risks elevated blood glucose and potentially serious complications, including renal impairment and visual disturbances. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include abdominal discomfort, bloating, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetol 0.2mg itself doesn't induce hypoglycemia, concomitant use with other anti-diabetics (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your doctor of any pre-existing hepatic or renal conditions before initiating treatment. This medication is contraindicated in individuals with inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical counsel prior to use. Complete disclosure of all medications being taken is crucial for patient safety. Limit alcohol consumption while using Diabetol 0.2mg to minimize the risk of hypoglycemia.
Primary Ingredients of Voglimark 0.2mg Tablet
No text was provided to rewrite.
Uses of Voglimark 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglimark 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimark 0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Voglimark 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglimark 0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 0.2mg Voglimark tablet whole; avoid chewing, crushing, or fracturing it. Consumption should be on an empty stomach.
How Voglimark 0.2mg Tablet works:
Voglimark 0.2mg tablets function as an antidiabetic medication by suppressing the activity of intestinal enzymes that digest complex carbohydrates. This action reduces postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Voglimark 0.2mg Tablet is contraindicated.
PregnancySAFE IF PRESCRIBED
Pregnant individuals may generally use Voglimark 0.2mg tablets safely. Animal research indicates minimal or absent harm to the fetus; nevertheless, human data are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglimark 0.2mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglimark 0.2mg tablets.
KidneyCAUTION
Exercise caution when administering Voglimark 0.2mg tablets to individuals with significant renal impairment. Dosage modification of Voglimark 0.2mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Voglimark 0.2mg tablets to individuals with advanced hepatic impairment. Dosage modification for Voglimark 0.2mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Voglimark 0.2mg Tablet :
Omit any missed Voglimark 0.2mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimark 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
